Shiloh
Editor, Senior Moderator
Source: http://www.usatoday.com/story/news/nation/2014/10/29/meningitis-vaccine-approved/18123013/
FDA approves new vaccine for meningitis B
Liz Szabo, USA TODAY 4:01 p.m. EDT October 29, 2014
The Food and Drug Administration announced today the approval of Trumenba, the first vaccine licensed in the United States to prevent invasive meningococcal disease caused by serogroup B.
The Food and Drug Administration today gave accelerated approval to a new meningitis vaccine that targets the strain of the bacteria that caused outbreaks at Princeton University and the University of California-Santa Barbara last year.
Many colleges require or recommend that new students be vaccinated against meningococcal disease. The bacteria causes meningitis, the sometimes life-threatening inflammation of the lining around the brain and spinal cord, and dangerous bloodstream infections. The disease can spread quickly in shared living areas such as dormitories and military barracks.
Until today, vaccines targeted only four of the five major kinds of meningococcal bacteria -- types A, C, Y and W. The new vaccine, called Trumenba, protects against type B...
FDA approves new vaccine for meningitis B
Liz Szabo, USA TODAY 4:01 p.m. EDT October 29, 2014
The Food and Drug Administration announced today the approval of Trumenba, the first vaccine licensed in the United States to prevent invasive meningococcal disease caused by serogroup B.
The Food and Drug Administration today gave accelerated approval to a new meningitis vaccine that targets the strain of the bacteria that caused outbreaks at Princeton University and the University of California-Santa Barbara last year.
Many colleges require or recommend that new students be vaccinated against meningococcal disease. The bacteria causes meningitis, the sometimes life-threatening inflammation of the lining around the brain and spinal cord, and dangerous bloodstream infections. The disease can spread quickly in shared living areas such as dormitories and military barracks.
Until today, vaccines targeted only four of the five major kinds of meningococcal bacteria -- types A, C, Y and W. The new vaccine, called Trumenba, protects against type B...